title: Lenalidomide plus Rituximab for Mantle-Cell Lymphoma.
authors.affiliation: Teikyo University Chiba Medical Center, Chiba, Japan thedod3@hotmail.com.
authors.forename: Kenji
authors.initials: K
authors.lastname: Tsuda
authors.affiliation: Navitas Clinic, Tokyo, Japan.
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Tanimoto
authors.affiliation: Teikyo University Chiba Medical Center, Chiba, Japan.
authors.forename: Tsunehiko
authors.initials: T
authors.lastname: Komatsu
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D008297:Male; D013792:Thalidomide / Q000031:analogs & derivatives*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D013792:Thalidomide